DnB Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-45,279
Closed -$3.42M 1314
2026
Q1
$3.42M Buy
45,279
+2,125
+5% +$160K 0.01% 514
2025
Q4
$3.21M Sell
43,154
-221,039
-84% -$16.2M 0.01% 535
2025
Q3
$17.8M Buy
264,193
+4,179
+2% +$277K 0.07% 200
2025
Q2
$16.9M Sell
260,014
-4,887
-2% -$293K 0.07% 183
2025
Q1
$16.4M Buy
264,901
+18,616
+8% +$1.23M 0.08% 182
2024
Q4
$17.8M Buy
246,285
+35,662
+17% +$2.79M 0.08% 181
2024
Q3
$17.2M Buy
210,623
+7,235
+4% +$579K 0.08% 186
2024
Q2
$15.1M Buy
203,388
+35,182
+21% +$2.64M 0.07% 178
2024
Q1
$13.1M Sell
168,206
-3,479
-2% -$259K 0.07% 200
2023
Q4
$12.3M Sell
171,685
-2,536
-1% -$177K 0.06% 223
2023
Q3
$12.1M Buy
174,221
+2,386
+1% +$180K 0.07% 207
2023
Q2
$13.9M Buy
171,835
+2,557
+2% +$209K 0.08% 184
2023
Q1
$13.7M Sell
169,278
-16,832
-9% -$1.36M 0.09% 174
2022
Q4
$13.9M Buy
186,110
+5,738
+3% +$409K 0.1% 177
2022
Q3
$11.6M Sell
180,372
-1,475
-0.8% -$102K 0.09% 189
2022
Q2
$12.6M Buy
181,847
+1,563
+0.9% +$116K 0.09% 192
2022
Q1
$13.8M Sell
180,284
-49,626
-22% -$3.57M 0.08% 192
2021
Q4
$17.6M Buy
229,910
+7,025
+3% +$516K 0.1% 171
2021
Q3
$16.5M Sell
222,885
-9,384
-4% -$704K 0.11% 165
2021
Q2
$15.5M Buy
232,269
+48,239
+26% +$3.22M 0.1% 159
2021
Q1
$13.7M Sell
184,030
-31,727
-15% -$2.41M 0.1% 160
2020
Q4
$15.7M Buy
215,757
+88,814
+70% +$6.27M 0.14% 135
2020
Q3
$8.44M Buy
126,943
+103,985
+453% +$6.58M 0.09% 165
2020
Q2
$1.31M Hold
22,958
0.02% 468
2020
Q1
$806K Sell
22,958
-6,482
-22% -$309K 0.01% 514
2019
Q4
$1.54M Sell
29,440
-200
-0.7% -$9.96K 0.02% 503
2019
Q3
$1.5M Buy
29,640
+1,407
+5% +$69.2K 0.02% 481
2019
Q2
$1.36M Sell
28,233
-3,595
-11% -$166K 0.02% 491
2019
Q1
$1.54M Buy
31,828
+23
+0.1% +$1.04K 0.02% 470
2018
Q4
$1.31M Hold
31,805
0.02% 482
2018
Q3
$1.3M Buy
31,805
+400
+1% +$16.2K 0.01% 494
2018
Q2
$1.25M Buy
31,405
+1,800
+6% +$69.2K 0.01% 489
2018
Q1
$1.11M Buy
29,605
+1,800
+6% +$72.7K 0.01% 488
2017
Q4
$1.19M Sell
27,805
-31,200
-53% -$1.24M 0.01% 468
2017
Q3
$2.16M Buy
59,005
+31,200
+112% +$1.26M 0.03% 331
2017
Q2
$1.26M Buy
27,805
+8,300
+43% +$366K 0.02% 420
2017
Q1
$830K Buy
19,505
+2,300
+13% +$93.8K 0.01% 487
2016
Q4
$690K Buy
17,205
+3,800
+28% +$147K 0.01% 472
2016
Q3
$521K Hold
13,405
0.01% 474
2016
Q2
$464K Buy
13,405
+1,000
+8% +$34.6K 0.01% 473
2016
Q1
$428K Sell
12,405
-800
-6% -$27.9K 0.01% 473
2015
Q4
$511K Sell
13,205
-10,400
-44% -$405K 0.01% 401
2015
Q3
$924K Sell
23,605
-1,500
-6% -$59.5K 0.02% 322
2015
Q2
$955K Buy
25,105
+5,800
+30% +$203K 0.02% 336
2015
Q1
$638K Sell
19,305
-9,800
-34% -$301K 0.01% 394
2014
Q4
$778K Hold
29,105
0.02% 382
2014
Q3
$708K Hold
29,105
0.02% 381
2014
Q2
$738K Buy
+29,105
New +$680K 0.02% 377

Other funds holding HOLX

DnB Asset Management's HOLX Position: Q2 2026 in Review

DnB Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 45,279 shares — an estimated $3.42M sold.

DnB Asset Management first reported a position in HOLX in Q2 2014 and held it in 48 quarters. The position peaked at $17.8M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • DnB Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • DnB Asset Management sold 45,279 Hologic shares in Q2 2026, an estimated $3.42M.
  • DnB Asset Management first reported a position in Hologic in Q2 2014 and held it in 48 quarters.
  • DnB Asset Management's Hologic position peaked at $17.8M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.